Table 5.
Comparison of hiPSC-based disease modeling approaches
| Innate | Engineered | Induced | |
|---|---|---|---|
| + | Disease modeled against patients' genetic background | ↓Need for patient recruitment | Enables modeling of noncongenital conditions |
| Isogenic disease and control lines | |||
| − | Patient recruitment difficult | Time consuming | Induced conditions may not accurately recapitulate disease |
| Nonisogenic disease and control lines | Costly | ||
| Potential risk for genomic instability |
The advantages (+) and disadvantages (−) of innate, induced, and engineered hiPSC-based disease models. ↓, Reduced.